Get the latest Science News and Discoveries
Derivatives of the thalidomide compound drive resistant cancer cells to their deaths - EurekAlert
<strong>A study by Goethe University Frankfurt points to the possibility that thalidomide derivatives are potentially suitable for treating cancer. Thalidomide was marketed in the 1950s as a sleeping pill. It later gained sad notoriety for causing severe fetal abnormalities in the early stages of pregnancy. It is meanwhile known that the molecule marks proteins in the cell for degradation. For the current study, the researchers produced thalidomide derivatives. They were able to show that these influence the degradation of proteins responsible for the survival of cancer cells.</strong>
None
Or read this on Eureka Alert